Literature DB >> 18945323

The burden of lung disease in Hong Kong: a report from the Hong Kong Thoracic Society.

Moira Chan-Yeung1, Christopher K W Lai, Kin-Sang Chan, Amy H K Cheung, Tzy-Jyun Yao, Alice S S Ho, Fanny W Ko, Loretta Y Yam, Poon-Chuen Wong, Kenneth W Tsang, Wah-Kit Lam, James C Ho, Chung-Ming Chu, Wai-Cho Yu, Hok-Sum Chan, Mary S M Ip, David S Hui, Cheuk-Yin Tam.   

Abstract

BACKGROUND AND
OBJECTIVE: The burden of lung disease in Hong Kong is not known. This study determined the mortality and hospitalization rates of respiratory diseases in Hong Kong in 2005, their trend in the past decade and their incidence/prevalence.
METHODS: Mortality data were obtained from the Department of Health and hospitalization data from the Hospital Authority, Hong Kong. Incidence/prevalence data were obtained from local registries or local studies. Trends of mortality and hospitalization rates of various respiratory diseases from 1997 and 2005 were calculated after age standardization and were tested for significance using negative binomial regression analysis. Age standardized mortality rates in Hong Kong were compared with those of the UK and globally.
RESULTS: Respiratory disease was the most common cause of mortality and hospitalization in Hong Kong in 2005. Globally and in the UK, cardiovascular disease ranked first in mortality. Respiratory infections ranked first in respiratory mortality, followed by respiratory tract cancer and chronic obstructive lung disease. Respiratory infections also ranked first followed by chronic obstructive lung disease in the utilization of respiratory inpatient bed-days. While mortality rates from all respiratory diseases decreased in the past decade, hospitalization rates remained unchanged. Unlike other respiratory diseases, mortality from respiratory infections have increased since 2001. Smoking is the most important risk factor in non-communicable respiratory diseases.
CONCLUSIONS: Respiratory disease is responsible for the highest health-care burden locally. Increased efforts in improving management and prevention of these diseases, including tobacco control, improving air quality and vaccination against influenza and pneumococci, are necessary.

Entities:  

Mesh:

Year:  2008        PMID: 18945323     DOI: 10.1111/j.1440-1843.2008.01394.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  12 in total

1.  Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD).

Authors:  Wai Cho Yu; Sau Nga Fu; Emily Lai-Bun Tai; Yiu Cheong Yeung; Kwok Chu Kwong; Yui Chang; Cheuk Ming Tam; Yuk Kwan Yiu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-08-26

Review 2.  Global impact of bronchiectasis and cystic fibrosis.

Authors:  Margarida Redondo; Holly Keyt; Raja Dhar; James D Chalmers
Journal:  Breathe (Sheff)       Date:  2016-09

3.  Adherence to a COPD treatment guideline among patients in Hong Kong.

Authors:  Ka Pang Chan; Fanny Ws Ko; Hok Sum Chan; Mo Lin Wong; Thomas Yw Mok; Kah Lin Choo; David Sc Hui
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-11-28

Review 4.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

5.  Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong - computerized data collection and analysis.

Authors:  Hok Sum Chan; Fanny Wai San Ko; Johnny Wai Man Chan; Loletta Kit Ying So; David Chi Leung Lam; Veronica Lee Chan; Cheuk Yin Tam; Wai Cho Yu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-13

Review 6.  Rising Strengths Hong Kong SAR in Bioinformatics.

Authors:  Chiranjib Chakraborty; C George Priya Doss; Hailong Zhu; Govindasamy Agoramoorthy
Journal:  Interdiscip Sci       Date:  2016-03-09       Impact factor: 2.233

7.  Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore.

Authors:  Hwee Pin Phua; Wei-Yen Lim; Ganga Ganesan; Joanne Yoong; Kelvin Bryan Tan; John Arputhan Abisheganaden; Albert Yick Hou Lim
Journal:  ERJ Open Res       Date:  2021-10-25

8.  Correlates of disease-specific knowledge in Chinese patients with COPD.

Authors:  Carlos Kh Wong; W C Yu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-14

9.  KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea.

Authors:  Hyun Lee; Hayoung Choi; Yun Su Sim; Shinhee Park; Woo Jin Kim; Kwang Ha Yoo; Seung Jun Lee; Tae-Hyung Kim; Bumhee Yang; Ina Jeong; Soo-Jung Um; Deog Kyeom Kim; Ji-Hyun Lee; Byoung Soo Kwon; Young-Jae Cho; Hye Yun Park; Chang-Hoon Lee; Chin Kook Rhee; Sang Haak Lee; Ju Ock Na; An-Soo Jang; Ji Ye Jung; Seung Won Ra; Ji-Ho Lee; Sang-Ha Kim; Changhwan Kim; Youlim Kim; Chang Youl Lee; Hyun Kuk Kim; Jae Seung Lee; Sei Won Lee; Yeon-Mok Oh
Journal:  BMJ Open       Date:  2020-01-19       Impact factor: 2.692

Review 10.  Acute exacerbation of COPD.

Authors:  Fanny W Ko; Ka Pang Chan; David S Hui; John R Goddard; Janet G Shaw; David W Reid; Ian A Yang
Journal:  Respirology       Date:  2016-03-30       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.